The rise in public and private healthcare expenditures and a strong growth in the market for adult vaccines is expected to propel the Indian vaccine market to grow at a CAGR of over 15% during the coming years. This report provides an analytical and statistical insight into the Indian vaccine market including BCG, HIB, Influenza, Varicella, Typhoid, Japanese Encephalitis, Measles, Tetanus Toxoid, Hepatitis A, Rubella, DPT, Polio, MMR, Rotavirus, Hepatitis B, Pneumococcal, Meningococcal, etc. Read Full Report Here: http://www.imarcgroup.com/indian-vaccine-market

1. Indian Vaccine Market Report
and Forecast 2015-2019
Imarc
www.imarcgroup.com
Copyright © 2015 International Market Analysis Research & Consulting (IMARC). All Rights Reserved
Consulting Services

2. The International Market Analysis Research and Consulting Group is a leading advisor on
management strategy and market research worldwide. We partner with clients in all sectors and
regions to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology organizations.
Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals,
food and beverage, travel and tourism, nanotechnology and novel processing methods are at the
top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.
About IMARC Group
Imarc
www.imarcgroup.com

3. Report Description and Highlights
Imarc
www.imarcgroup.com
The Indian Vaccine Market: Current Market Trends and Future Prospects
A new report expects the Indian vaccine market to grow at a CAGR of 15% in the coming years. The sustained
growth of the Indian economy, a consequent rise in public and private healthcare expenditures, 25-30 million
births every year and a strong growth in the market for adult vaccines are expected to be the main factors
catalyzing this growth.
The market for vaccines in India shows immense potential. The country has not only been self-sufficient in
meeting its domestic requirements but has also emerged as a leading global exporter of vaccines across the
world. The Indian vaccine industry began as a network of state owned manufacturers supplying basic childhood
vaccines to the national immunization programme. In recent decades, however, a number of privately owned
firms have emerged which have completely transformed the industry landscape. Their biggest success factor is
similar to the approach that has been followed by Indian generic pharmaceutical manufacturers. This model
involved concerted efforts to develop vaccines for not only tropical neglected diseases, but also cheaper
alternatives of vaccines that are already available in the West.
Despite its recent growth, however, the Indian vaccine industry still has a number of challenges to address. The
market remains small (currently accounts for less than 2% of the global market) and underpenetrated compared
to the developed countries. The country also lags behind its global peers in terms of vaccine coverage with a
significant number of lives lost due to vaccine preventable deaths. Nevertheless, despite these challenges the
situation appears bright for vaccine manufacturers. The country has around 25-30 Million births each year. This
coupled with the sustained growth of the Indian economy, a consequent rise in public and private healthcare
expenditures and a strong growth in the market for adult vaccines is expected to propel the Indian vaccine
market to grow at a CAGR of over 15% during the coming years.

4. Report Description and Highlights
Imarc
www.imarcgroup.com
IMARC’s new report entitled “Indian Vaccine Market Report and Forecast 2015-2019” provides an analytical and
statistical insight into the Indian vaccine market. The study is an outcome of an intensive research on the Indian
vaccine industry and draws upon a comprehensive analysis of every major vaccine in India. The report can serve
as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning
to foray into the Indian vaccine market in any form.
Key Vaccines Covered in the Report
BCG, HIB, Influenza, Varicella, Typhoid, Japanese Encephalitis, Measles, Tetanus Toxoid, Hepatitis A, Rubella,
DPT, Polio, MMR, Rotavirus, Hepatitis B, Pneumococcal, Meningococcal, Rabies, HPV
Focus of the Analysis for Each Vaccine
• Vaccine Overview and Epidemiology
• Historical and Current Market Trends
• Market Breakup by Prescriber
• Market Breakup by Public and Private Sector
• Market Outlook
Table of Contents
1. Research Methodology and Market Definitions
2. Executive Summary
3. Indian Vaccine Market
3.1 Introduction and History
3.2 Current and Historical Market Trends

5. Indian Vaccine Market
Imarc
www.imarcgroup.com

6. Report Description and Highlights
Imarc
www.imarcgroup.com
3.3 Market Breakup by Segment
3.4 Market Breakup by Key Players
3.5 Market Drivers and Challenges
3.6 Market Outlook
4. Market Analysis of Various Monovalent and Combined Vaccines
4.1 BCG Vaccine Market
4.1.1 Vaccine Overview and Epidemiology
4.1.2 Historical and Current Market Trends
4.1.3 Market Breakup by Prescriber
4.1.4 Market Breakup by Public and Private Sectors
4.1.5 Market Outlook
4.2 HIB Vaccine Market
4.2.1 Vaccine Overview and Epidemiology
4.2.2 Historical and Current Market Trends
4.2.3 Market Breakup by Prescriber
4.2.4 Market Breakup by Public and Private Sectors
4.2.5 Market Outlook
4.3 Influenza Vaccine Market
4.3.1 Vaccine Overview and Epidemiology
4.3.2 Historical and Current Market Trends
4.3.3 Market Breakup by Prescriber
4.3.4 Market Breakup by Public and Private Sectors
4.3.5 Market Outlook
4.4 Varicella Vaccine Market
4.4.1 Vaccine Overview and Epidemiology

7. Report Description and Highlights
Imarc
www.imarcgroup.com
4.4.2 Historical and Current Market Trends
4.4.3 Market Breakup by Prescriber
4.4.4 Market Breakup by Public and Private Sectors
4.4.5 Market Outlook
4.5 Typhoid Vaccine Market
4.5.1 Vaccine Overview and Epidemiology
4.5.2 Historical and Current Market Trends
4.5.3 Market Breakup by Prescriber
4.5.4 Market Breakup by Public and Private Sectors
4.5.5 Market Outlook
4.6 Japanese Encephalitis Vaccine Market
4.6.1 Vaccine Overview and Epidemiology
4.6.2 Historical and Current Market Trends
4.6.3 Market Breakup by Prescriber
4.6.4 Market Breakup by Public and Private Sectors
4.6.5 Market Outlook
4.7 Measles Vaccine Market
4.7.1 Vaccine Overview and Epidemiology
4.7.2 Historical and Current Market Trends
4.7.3 Market Breakup by Prescriber
4.7.4 Market Breakup by Public and Private Sectors
4.7.5 Market Outlook
4.8 Tetanus Toxoid Vaccine Market
4.8.1 Vaccine Overview and Epidemiology
4.8.2 Historical and Current Market Trends

8. Report Description and Highlights
Imarc
www.imarcgroup.com
4.8.3 Market Breakup by Prescriber
4.8.4 Market Breakup by Public and Private Sectors
4.8.5 Market Outlook
4.9 Hepatitis A Vaccine Market
4.9.1 Vaccine Overview and Epidemiology
4.9.2 Historical and Current Market Trends
4.9.3 Market Breakup by Prescriber
4.9.4 Market Breakup by Public and Private Sectors
4.9.5 Market Outlook
4.10 Rubella Vaccine Market
4.10.1 Vaccine Overview and Epidemiology
4.10.2 Historical and Current Market Trends
4.10.3 Market Breakup by Prescriber
4.10.4 Market Breakup by Public and Private Sectors
4.10.5 Market Outlook
4.11 DPT Vaccine Market
4.11.1 Vaccine Overview and Epidemiology
4.11.2 Historical and Current Market Trends
4.11.3 Market Breakup by Prescriber
4.11.4 Market Breakup by Public and Private Sectors
4.11.5 Market Outlook
4.12 Polio Vaccine Market
4.12.1 Vaccine Overview and Epidemiology
4.12.2 Historical and Current Market Trends
4.12.3 Market Breakup by Prescriber

9. Report Description and Highlights
Imarc
www.imarcgroup.com
4.12.4 Market Breakup by Public and Private Sectors
4.12.5 Market Outlook
4.13 MMR Vaccine Market
4.13.1 Vaccine Overview and Epidemiology
4.13.2 Historical and Current Market Trends
4.13.3 Market Breakup by Prescriber
4.13.4 Market Breakup by Public and Private Sectors
4.13.5 Market Outlook
4.14 Rotavirus Vaccine Market
4.14.1 Vaccine Overview and Epidemiology
4.14.2 Historical and Current Market Trends
4.14.3 Market Breakup by Prescriber
4.14.4 Market Breakup by Public and Private Sectors
4.14.5 Market Outlook
4.15 Hepatitis B Vaccine Market
4.15.1 Vaccine Overview and Epidemiology
4.15.2 Historical and Current Market Trends
4.15.3 Market Breakup by Prescriber
4.15.4 Market Breakup by Public and Private Sectors
4.15.5 Market Outlook
4.16 Pneumococcal Vaccine Market
4.16.1 Vaccine Overview and Epidemiology
4.16.2 Historical and Current Market Trends
4.16.3 Market Breakup by Prescriber
4.16.4 Market Breakup by Public and Private Sectors

10. Report Description and Highlights
Imarc
www.imarcgroup.com
4.16.5 Market Outlook
4.17 Meningococcal Vaccine Market
4.17.1 Vaccine Overview and Epidemiology
4.17.2 Historical and Current Market Trends
4.17.3 Market Breakup by Prescriber
4.17.4 Market Breakup by Public and Private Sectors
4.17.5 Market Outlook
4.18 Rabies Vaccine Market
4.18.1 Vaccine Overview and Epidemiology
4.18.2 Historical and Current Market Trends
4.18.3 Market Breakup by Prescriber
4.18.4 Market Breakup by Public and Private Sectors
4.18.5 Market Outlook
4.19 HPV Vaccine Market
4.19.1 Vaccine Overview and Epidemiology
4.19.2 Historical and Current Market Trends
4.19.3 Market Breakup by Prescriber
4.19.4 Market Breakup by Public and Private Sectors
4.19.5 Market Outlook
5. Regulatory Framework

11. Report Description and Highlights
Imarc
www.imarcgroup.com
List of Figures
Figure 1: Vaccine Development and Introduction in Indian Vaccine Market
Figure 2: Comparison of Global Vaccine Market and Indian Vaccine Market
Figure 3: India: Vaccine Market: Sales Value (in Billion INR), 2007 - 2014
Figure 4: India: Vaccine Market: Healthcare and Immunization Budget (In Billion INR), 2007 - 2014
Figure 5: India: Vaccine Market: Standard Procedure of Introducing New Vaccine
Figure 6: India: Vaccine Market: Spending by Different Organizations on Polio Program
Figure 7: India: Vaccine Market: Vaccine Coverage in Uttar Pradesh and Tamil Nadu
Figure 8: India: Vaccine Market: Value Breakup by Therapies (in %), 2014
Figure 9: India: Monovalent Vaccine Market: Value Breakup by Vaccine (in %), 2014
Figure 10: India: Combined Vaccine Market: Value Breakup by Vaccine (in %), 2014
Figure 11: India: Vaccine Market: Value Breakup by Key Players (in %), 2014
Figure 12: India: BCG Vaccine Market: Sales Value (in Million INR), 2007 - 2014
Figure 13: India: BCG Vaccine Market: Doses Administered (in Million), 2007 - 2014
Figure 14: India: BCG Vaccine Market: Breakup by Prescriber (in %), 2014
Figure 15: India: BCG Vaccine Market: Breakup by Sector (in %), 2014
Figure 16: India: BCG Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
Figure 17: India: BCG Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
Figure 18: India: HIB Vaccine Market: Sales Value (in Million INR), 2007 - 2014
Figure 19: India: HIB Vaccine Market: Doses Administered (in ‘000), 2007 - 2014
Figure 20: India: HIB Vaccine Market: Breakup by Prescriber (in %), 2014
Figure 21: India: HIB Vaccine Market: Breakup by Sector (in %), 2014
Figure 22: India: HIB Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
Figure 23: India: HIB Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
Figure 24: India: Influenza Vaccine Market: Sales value (in Million INR), 2010 - 2014

12. Report Description and Highlights
Imarc
www.imarcgroup.com
Figure 25: India: Influenza Vaccine Market: Doses Administered (in Million), 2010 - 2014
Figure 26: India: Influenza Vaccine Market: Breakup by Prescriber (in %), 2014
Figure 27: India: Influenza Vaccine Market: Breakup by Sector (in %), 2014
Figure 28: India: Influenza Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
Figure 29: India: Influenza Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
Figure 30: India: Varicella Vaccine Market: Sales Value (in Million INR), 2007 - 2014
Figure 31: India: Varicella Vaccine Market: Doses Administered (in Million), 2007 - 2014
Figure 32: India: Varicella Vaccine Market: Breakup by Prescriber (in %), 2014
Figure 33: India: Varicella Vaccine Market: Breakup by Sector (in %), 2014
Figure 34: India: Varicella Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
Figure 35: India: Varicella Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
Figure 36: India: Typhoid Vaccine Market: Sales value (in Million INR), 2007 - 2014
Figure 37: India: Typhoid Vaccine Market: Doses Administered (in Million), 2007 - 2014
Figure 38: India: Typhoid Vaccine Market: Breakup by Prescriber (in %), 2014
Figure 39: India: Typhoid Vaccine Market: Breakup by Sector (in %), 2014
Figure 40: India: Typhoid Vaccine Market: Sales Value Forecast (in Millions INR), 2015 - 2019
Figure 41: India: Typhoid Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
Figure 42: India: JE Vaccine Market: Sales Value (in Million INR), 2007 - 2014
Figure 43: India: JE Vaccine Market: Doses Administered (in Million), 2007 - 2014
Figure 44: India: JE Vaccine Market: Breakup by Prescriber (in %), 2014
Figure 45: India: JE Vaccine Market: Breakup by Sector (in %), 2014
Figure 46: India: JE Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
Figure 47: India: JE Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
Figure 48: India: Measles Vaccine Market: Sales Value (in Million INR), 2007 – 2014
Figure 49: India: Measles Vaccine Market: Doses Administered (in Million), 2007 - 2014
Figure 50: India: Measles Vaccine Market: Breakup by Prescriber (in %), 2014

13. Report Description and Highlights
Imarc
www.imarcgroup.com
Figure 51: India: Measles Vaccine Market: Breakup by Sector (in %), 2014
Figure 52: India: Measles Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
Figure 53: India: Measles Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
Figure 54: India: TT Vaccine Market: Sales Value (in Million INR), 2007 - 2014
Figure 55: India: TT Vaccine Market: Doses Administered (in Million), 2007 - 2014
Figure 56: India: TT Vaccine Market: Breakup by Prescriber (in %), 2014
Figure 57: India: TT Vaccine Market: Breakup by Sector (in %), 2014
Figure 58: India: TT Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
Figure 59: India: TT Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
Figure 60: India: Hepatitis A Vaccine Market: Sales Value (in Million INR), 2007 - 2014
Figure 61: India: Hepatitis A Vaccine Market: Doses Administered (in Million), 2007 - 2014
Figure 62: India: Hepatitis A Vaccine Market: Breakup by Prescriber (in %), 2014
Figure 63: India: Hepatitis A Vaccine Market: Breakup by Sector (in %), 2014
Figure 64: India: Hepatitis A Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
Figure 65: India: Hepatitis A Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
Figure 66: India: Rubella Vaccine Market: Sales Value (in Million INR), 2007 - 2014
Figure 67: India: Rubella Vaccine Market: Doses Administered (in Million), 2007 - 2014
Figure 68: India: Rubella Vaccine Market: Breakup by Prescriber (in %), 2014
Figure 69: India: Rubella Vaccine Market: Breakup by Sector (in %), 2014
Figure 70: India: Rubella Vaccine Market: Sales Value Forecast (in Million INR), 2015 – 2019
Figure 71: India: Rubella Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
Figure 72: India: DPT Vaccine Market: Sales Value (in Million INR), 2007 - 2014
Figure 73: India: DPT Vaccine Market: Doses Administered (in Million), 2007 - 2014
Figure 74: India: DPT Vaccine Market: Breakup by Prescriber (in %), 2014
Figure 75: India: DPT Vaccine Market: Breakup by Sector (in %), 2014
Figure 76: India: DPT Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019

14. Report Description and Highlights
Imarc
www.imarcgroup.com
Figure 77: India: DPT Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
Figure 78: India: Polio Vaccine: Incidence of Polio, 2007 - 2014
Figure 79: India: Polio Vaccine Market: Sales Value (in Million INR), 2007 - 2014
Figure 80: India: Polio Vaccine Market: Doses Administered (in Million), 2007 - 2014
Figure 81: India: Polio Vaccine Market: Breakup by Prescriber (in %), 2014
Figure 82: India: Polio Vaccine Market: Breakup by Sector (in %), 2014
Figure 83: India: Polio Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
Figure 84: India: Polio Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
Figure 85: India: MMR Vaccine Market: Sales Value (in Million INR), 2007 - 2014
Figure 86: India: MMR Vaccine Market: Doses Administered (in Million), 2007 - 2014
Figure 87: India: MMR Vaccine Market: Breakup by Prescriber (in %), 2014
Figure 88: India: MMR Vaccine Market: Breakup by Sector (in %), 2014
Figure 89: India: MMR Vaccine Market: Sales Value Forecast (in INR Million), 2015 - 2019
Figure 90: India: MMR Vaccine Market: Doses Administered Forecast (In Million), 2015 - 2019
Figure 91: India: Rotavirus Vaccine Market: Sales Value (in Million INR), 2010-2014
Figure 92: India: Rotavirus Vaccine Market: Doses Administered (in Million), 2010-2014
Figure 93: India: Rotavirus Vaccine Market: Breakup by Prescriber (In %), 2014
Figure 94: India: Rotavirus Vaccine Market: Breakup by Sector (in %), 2014
Figure 95: India: Rotavirus Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
Figure 96: India: Rotavirus Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
Figure 97: India: Hepatitis B Vaccine Market: Sales Value (in Million INR), 2007 - 2014
Figure 98: India: Hepatitis B Vaccine Market: Doses Administered (in Million), 2007 - 2014
Figure 99: India: Hepatitis B Vaccine Market: Breakup by Prescriber (in %), 2014
Figure 100: India: Hepatitis B Vaccine Market: Breakup by Sector (in %), 2014
Figure 101: India: Hepatitis B Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
Figure 102: India: Hepatitis B Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019

15. Report Description and Highlights
Imarc
www.imarcgroup.com
Figure 103: India: Pneumonia Vaccine Market: Sales Value (in Million INR), 2007 - 2014
Figure 104: India: Pneumonia Vaccine Market: Doses Administered (in Million), 2007 - 2014
Figure 105: India: Pneumonia Vaccine Market: Breakup by Prescriber (in %), 2014
Figure 106: India: Pneumonia Vaccine Market: Breakup by Sector (in %), 2014
Figure 107: India: Pneumonia Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
Figure 108: India: Pneumonia Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
Figure 109: India: Meningococcal Vaccine Market: Sales Value (in Million INR), 2007 - 2014
Figure 110: India: Meningococcal Vaccine Market: Doses Administered (in Million), 2007 - 2014
Figure 111: India: Polio Vaccine Market: Breakup by Prescriber (in %), 2014
Figure 112: India: Polio Vaccine Market: Breakup by Sector (in %), 2014
Figure 113: India: Meningococcal Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
Figure 114: India: Meningococcal Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
Figure 115: India: Rabies Vaccine Market: Sales Value (in Million INR), 2007 - 2014
Figure 116: India: Rabies Vaccine Market: Doses Administered (in Million), 2007 - 2014
Figure 117: India: Polio Vaccine Market: Breakup by Prescriber (in %), 2014
Figure 118: India: Polio Vaccine Market: Breakup by Sector (in %), 2014
Figure 119: India: Rabies Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
Figure 120: India: Rabies Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
Figure 121: India: HPV Vaccine Market: Sales Value (in Million INR), 2007 - 2014
Figure 122: India: HPV Vaccine Market: Doses Administered (in Million), 2007 - 2014
Figure 123: India: HPV Vaccine Market: Breakup by Prescriber (in %), 2014
Figure 124: India: HPV Vaccine Market: Breakup by Sector (in %), 2014
Figure 125: India: HPV Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
Figure 126: India: HPV Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019

16. Report Description and Highlights
Imarc
www.imarcgroup.com
List of Tables
Table 1: India: Vaccine Market Overview
Table 2: India: Monovalent Vaccine Market: Value Breakup by Vaccine, 2014 and 2019
Table 3: India: Combined Vaccine Market: Value Breakup by Vaccine, 2014 and 2019
Table 4: India: Vaccine Market: Structural Barriers
Table 5: India: BCG Vaccine: Overview
Table 6: India: BCG Vaccine: Incidence of TB, 2013
Table 7: India: HIB Vaccine: Overview
Table 8: India: HIB Vaccine: Incidence of HIB, 2006 and 2013
Table 9: India: Influenza Vaccine: Overview
Table 10: India: Influenza Vaccine: Incidence of Influenza, 2011 and 2013
Table 11: India: Varicella Vaccine: Overview
Table 12: India: Varicella Vaccine: Incidence of Chickenpox, 2013
Table 13: India: Typhoid Vaccine: Overview
Table 14: India: Typhoid Vaccine: Incidence of Typhoid, 2013
Table 15: India: JE Vaccine: Overview
Table 16: India: JE Vaccine: Incidence of JE, 2012 and 2013
Table 17: India: Measles Vaccine: Overview
Table 18: India: Measles Vaccine: Incidence, 2007 - 2013
Table 19: India: Tetanus Toxoid Vaccine: Overview
Table 20: India: Tetanus Toxoid Vaccine: Incidence of Tetanus Toxoid, 2007 – 2013
Table 21: India: Hepatitis A Vaccine: Overview
Table 22: India: Hepatitis A Vaccine: Incidence of Hepatitis A, 2012 and 2013

17. Report Description and Highlights
Imarc
www.imarcgroup.com
Table 23: India: Rubella Vaccine: Overview
Table 24: India: Rubella Vaccine: Incidence of Rubella
Table 25: India: DPT Vaccine: Overview
Table 26: India: DPT Vaccine: Incidence of DPT, 2007 - 2013
Table 27: India: Polio Vaccine: Overview
Table 28: India: MMR Vaccine: Overview
Table 29: India: MMR Vaccine: Incidence of Measles, Mumps & Rubella, 2011 and 2013
Table 30: India: Rotavirus Vaccine: Overview
Table 31: India: Rotavirus Vaccine: Incidence of Rotavirus, 2013
Table 32: India: Hepatitis B Vaccine: Overview
Table 33: India: Hepatitis B Vaccine: Incidence of Hepatitis B, 2011 and 2014
Table 34: India: Pneumonia Vaccine: Overview
Table 35: India: Pneumonia Vaccine: Incidence of Pneumonia, 2012 and 2013
Table 36: India: Meningococcal Vaccine: Overview
Table 37: India: Meningococcal Vaccine: Incidence of Meningococcal, 2007 and 2013
Table 38: India: Rabies Vaccine: Overview
Table 39: India: Rabies Vaccine: Incidence of Rabies, 2013
Table 40: India: HPV Vaccine: Overview
Table 41: India: HPV Vaccine: Incidence of HPV, 2007 and 2014

18. Report Description and Highlights
Imarc
www.imarcgroup.com
To buy the complete report or to get a free sample, please contact:
IMARC Group Asia:
Email: apac@imarcgroup.com
Phone: +91-120-415-5099
IMARC Group North America:
Email: america@imarcgroup.com
Phone: +1-631-791-1145
IMARC Group Europe, Middle East & Africa:
Email: ema@imarcgroup.com
Phone: +44-702-409-7331
To know more please visit: http://www.imarcgroup.com/indian-vaccine-market

19. Report Description and Highlights
Imarc
www.imarcgroup.com
© 2015 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

20. FOR MORE DETAILS
Visit us at :
http://www.imarcgroup.com
Stay With Us:
TELEPHONE: +91-120-4155099
E-MAIL: sales@imarcgroup.com
Imarc
www.imarcgroup.com